Cardiovascular Flashcards
Calcium Channel Blockers Mechanism of Action
Prevent calcium moving into cardiac and smooth muscle cells resulting in decreased cardiac muscle contraction and conduction, and vasodilation of the coronary arteries and peripheral arterioles
- Decreases cardiac output
- Decreases HR
- Decreased coronary artery spasm
Which CCB decrease heart rate significantly?
Verapamil
Diltiazem
Which CCB cause significant vasodilation?
Dihydropyridines (nifedipine, amlodipine)
Calcium channel blockers Dihydropyridines clinical use
HTN
angina
Calcium channel blockers Non-dihydropyridines–clinical use
HTN
angina
atrial fibrillation/flutter
Calcium channel blockers non dihydropyridine–toxicity
cardiac depression
AV block
hyperprolactinemia
constipation
Calcium channel blockers dihydropyridine–toxicity
peripheral edema
flushing
dizziness
gingival hyperplasia
RAAS pathway
ACE inhibitors mechanism of action
Prevent angiotensin converting enzyme from converting angiotensin I to angiotensin II (vasodilator). Also stops breakdown of bradykinin (vasodilator).
Angiotensin Receptor Blocker mechanism of action
Prevent Angiotensin II from binding to receptor.
No impact on bradykinin.
ACE Inhibitor/ARB indications
- HTN
- CHF
- Acute/post MI
- Diabetic nephropathy
- Proteinuria
- Acute MI/post
ACE inhibitor/ARB Side Effects
Dizziness, hyperkalemia, elevated renal tests, angioedema
Dry cough in ACE inhibitors
Monitor renal function and electrolytes.
Thiazide diuretic indications
1st line therapy for hypertension (decreases risk for MI and CVA in HTN)
Edema
Thiazide diuretic adverse effects
- Hypokalemia
- Dehydration
- Hyperglycemia
- Hyperuricemia
- Hyperlipidemia
- Impotence
- Hyponatremia
Loop diuretic mechanism of action
Inhibit Na/K/Cl cotransporter in the Loop of Henle which inhibits reabsorption of sodium and chloride leading to increased water excretion
Loop diuretic adverse effects
- Risk of hypokalemia, hypocalcemia, hypomagnesemia, hyponatremia
- Hyperuricemia
- Hyperglycemia
- Ototoxicity